| Name | Shares allotted | % of global offering | % of post-IPO shares | Lock-up |
|---|---|---|---|---|
| Dragon Billion China Master Fund | 0 | 2.06% | — | 6 months |
| OrbiMed Funds | 0 | 2.07% | — | 6 months |
| TAL China Focus Master Fund | 0 | 1.24% | — | 6 months |
| 惠理基金管理香港有限公司 | 0 | 4.13% | — | 6 months |
| 麦格理基金管理(香港)有限公司 | 0 | 1.03% | — | 6 months |
| 五矿资本(香港)有限公司 | 0 | 1.03% | — | 6 months |
This page shows allotment analysis for Luye Pharma (02186): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

